Histopathological and molecular analyses

TG Tobias Goschzik
MM Martin Mynarek
ED Evelyn Doerner
AS Alina Schenk
IS Isabel Spier
MW Monika Warmuth-Metz
BB Brigitte Bison
DO Denise Obrecht
NS Nina Struve
RK Rolf-Dieter Kortmann
MS Matthias Schmid
SA Stefan Aretz
SR Stefan Rutkowski
TP Torsten Pietsch
ask Ask a question
Favorite

According to the WHO classification 2016, the tumor samples were classified after conventional (HE and reticulin) and immunohistochemical stainings including markers for pathway activation [8, 34].

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A